ZIMMER BIOMET HOLDINGS, INC. Operating Income
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Operating Income of $326.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for the quarter ending 2026-06-30 was $326.10M, a 8.70% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for the quarter ending 2026-03-31 was $373.20M, a 27.68% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for the quarter ending 2025-12-31 was $154.50M, a 60.28% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for the quarter ending 2025-09-30 was $351.30M, a 25.69% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for fiscal 2025 was $1.10B, a 14.59% decline from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for fiscal 2024 was $1.29B, a 0.63% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for fiscal 2023 was $1.28B, a 83.50% increase from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. operating income (loss) for fiscal 2022 was $696.30M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $326.10M 10-Q · filed 2026-08-05 | $699.20M 10-Q · filed 2026-08-05 | $853.80M derived: sum of 3 quarters · filed 2026-08-05 | $1.21B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $373.20M 10-Q · filed 2026-05-01 | $527.70M derived: sum of 2 quarters · filed 2026-05-01 | $879.00M derived: sum of 3 quarters · filed 2026-05-01 | $1.18B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $154.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $505.80M derived: sum of 2 quarters · filed 2026-02-20 | $805.80M derived: sum of 3 quarters · filed 2026-08-05 | $1.10B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $351.30M 10-Q · filed 2025-11-05 | $651.30M derived: sum of 2 quarters · filed 2026-08-05 | $943.60M 10-Q · filed 2025-11-05 | $1.33B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $300.00M 10-Q · filed 2026-08-05 | $592.30M 10-Q · filed 2026-08-05 | $981.30M derived: sum of 3 quarters · filed 2026-08-05 | $1.26B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $292.30M 10-Q · filed 2026-05-01 | $681.30M derived: sum of 2 quarters · filed 2026-05-01 | $960.80M derived: sum of 3 quarters · filed 2026-05-01 | $1.31B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $389.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $668.50M derived: sum of 2 quarters · filed 2026-02-20 | $1.02B derived: sum of 3 quarters · filed 2026-02-20 | $1.29B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $279.50M 10-Q · filed 2025-11-05 | $630.80M derived: sum of 2 quarters · filed 2025-11-05 | $896.70M 10-Q · filed 2025-11-05 | $1.25B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $351.30M 10-Q · filed 2025-08-07 | $617.20M 10-Q · filed 2025-08-07 | $971.40M derived: sum of 3 quarters · filed 2026-02-20 | $1.24B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $265.90M 10-Q · filed 2025-05-05 | $620.10M derived: sum of 2 quarters · filed 2026-02-20 | $886.70M derived: sum of 3 quarters · filed 2026-02-20 | $1.22B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $354.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $620.80M derived: sum of 2 quarters · filed 2026-02-20 | $950.40M derived: sum of 3 quarters · filed 2026-02-20 | $1.28B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $266.60M 10-Q · filed 2024-10-30 | $596.20M derived: sum of 2 quarters · filed 2024-10-30 | $923.50M 10-Q · filed 2024-10-30 | $895.20M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $329.60M 10-Q · filed 2024-08-07 | $656.90M 10-Q · filed 2024-08-07 | $628.60M derived: sum of 3 quarters · filed 2025-02-25 | $873.90M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $327.30M 10-Q · filed 2024-05-02 | $299.00M derived: sum of 2 quarters · filed 2025-02-25 | $544.30M derived: sum of 3 quarters · filed 2025-02-25 | $825.20M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$28.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $217.00M derived: sum of 2 quarters · filed 2025-02-25 | $497.90M derived: sum of 3 quarters · filed 2025-02-25 | $696.30M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $245.30M 10-Q · filed 2023-11-07 | $526.20M derived: sum of 2 quarters · filed 2023-11-07 | $724.60M 10-Q · filed 2023-11-07 | $858.40M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-06-30 | $280.90M 10-Q · filed 2023-08-01 | $479.30M 10-Q · filed 2023-08-01 | $613.10M derived: sum of 3 quarters · filed 2024-08-07 | $856.10M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-03-31 | $198.40M 10-Q · filed 2023-05-02 | $332.20M derived: sum of 2 quarters · filed 2024-08-07 | $575.20M derived: sum of 3 quarters · filed 2024-08-07 | $800.00M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2021-12-31 | $133.80M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $376.80M derived: sum of 2 quarters · filed 2024-08-07 | $601.60M derived: sum of 3 quarters · filed 2024-08-07 | $860.30M 8-K · filed 2024-08-07 | $780.10M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $243.00M 10-Q · filed 2022-11-02 | $214.90M 10-Q · filed 2021-11-04 | $467.80M derived: sum of 2 quarters · filed 2022-11-02 | $726.50M 10-Q · filed 2022-11-02 | $701.00M 10-Q · filed 2021-11-04 | $1.14B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | $224.80M 10-Q · filed 2022-08-02 | $220.50M 10-Q · filed 2021-08-03 | $483.50M 10-Q · filed 2022-08-02 | $486.10M 10-Q · filed 2021-08-03 | $895.10M derived: sum of 3 quarters · filed 2023-02-24 | $1.19B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-03-31 | $258.70M 10-Q · filed 2022-05-05 | $265.60M 10-Q · filed 2021-05-04 | $670.30M derived: sum of 2 quarters · filed 2023-02-24 | $969.50M derived: sum of 3 quarters · filed 2023-02-24 | $797.80M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $411.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $710.80M derived: sum of 2 quarters · filed 2023-02-24 | $539.10M derived: sum of 3 quarters · filed 2023-02-24 | $83.10M 10-K · filed 2023-02-24 | -$87.80M 10-K · filed 2021-02-22 | |||
| 2020-09-30 | $299.20M 10-Q · filed 2021-11-04 | $127.50M derived: sum of 2 quarters · filed 2021-11-04 | -$328.50M 10-Q · filed 2021-11-04 | -$17.20M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-06-30 | -$171.70M 10-Q · filed 2021-08-03 | -$627.70M 10-Q · filed 2021-08-03 | -$316.40M derived: sum of 3 quarters · filed 2022-06-22 | -$70.60M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-03-31 | -$456.00M 10-Q · filed 2021-05-04 | -$144.70M derived: sum of 2 quarters · filed 2022-06-22 | $101.10M derived: sum of 3 quarters · filed 2022-06-22 | $305.80M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2019-12-31 | $311.30M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $557.10M derived: sum of 2 quarters · filed 2022-06-22 | $761.80M derived: sum of 3 quarters · filed 2022-06-22 | $1.11B 8-K · filed 2022-06-22 | $1.14B 10-K · filed 2020-02-21 | |||
| 2019-09-30 | $245.80M 10-Q · filed 2020-11-06 | $450.50M derived: sum of 2 quarters · filed 2020-11-06 | $800.70M 10-Q · filed 2020-11-06 | $10.20M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $204.70M 10-Q · filed 2020-08-05 | $554.90M 10-Q · filed 2020-08-05 | -$235.60M derived: sum of 3 quarters · filed 2021-02-22 | -$12.30M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $350.20M 10-Q · filed 2020-05-11 | -$440.30M derived: sum of 2 quarters · filed 2021-02-22 | -$217.00M derived: sum of 3 quarters · filed 2021-02-22 | $79.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | -$790.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$567.20M derived: sum of 2 quarters · filed 2021-02-22 | -$271.20M derived: sum of 3 quarters · filed 2021-02-22 | $33.80M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $223.30M 10-Q · filed 2019-11-05 | $519.30M derived: sum of 2 quarters · filed 2019-11-05 | $824.30M 10-Q · filed 2019-11-05 | $784.20M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $296.00M 10-Q · filed 2019-08-05 | $601.00M 10-Q · filed 2019-08-05 | $560.90M derived: sum of 3 quarters · filed 2020-02-21 | $772.10M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $305.00M 10-Q · filed 2019-05-06 | $264.90M derived: sum of 2 quarters · filed 2020-02-21 | $476.10M derived: sum of 3 quarters · filed 2020-02-21 | $756.20M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | -$40.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $171.10M derived: sum of 2 quarters · filed 2020-02-21 | $451.20M derived: sum of 3 quarters · filed 2020-02-21 | $799.30M 10-K · filed 2020-02-21 | $808.20M 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $211.20M 10-Q · filed 2018-11-01 | $213.40M 10-Q · filed 2017-11-06 | $491.30M derived: sum of 2 quarters · filed 2018-11-01 | $839.40M 10-Q · filed 2018-11-01 | $846.10M 10-Q · filed 2017-11-06 | $1.02B derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $280.10M 10-Q · filed 2018-08-06 | $282.30M 10-Q · filed 2017-08-08 | $628.20M 10-Q · filed 2018-08-06 | $632.70M 10-Q · filed 2017-08-08 | $806.70M derived: sum of 3 quarters · filed 2019-02-26 | $1.00B derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $348.10M 10-Q · filed 2018-05-08 | $350.40M 10-Q · filed 2017-05-09 | $526.60M derived: sum of 2 quarters · filed 2019-02-26 | $722.10M derived: sum of 3 quarters · filed 2019-02-26 | $923.70M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $178.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $374.00M derived: sum of 2 quarters · filed 2019-02-26 | $575.60M derived: sum of 3 quarters · filed 2019-02-26 | $821.10M 10-K · filed 2019-02-26 | $825.90M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $195.50M 10-Q · filed 2017-11-06 | $397.10M derived: sum of 2 quarters · filed 2017-11-06 | $642.60M 10-Q · filed 2017-11-06 | $856.10M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $201.60M 10-Q · filed 2017-08-08 | $447.10M 10-Q · filed 2017-08-08 | $660.60M derived: sum of 3 quarters · filed 2018-02-27 | $776.60M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $245.50M 10-Q · filed 2017-05-09 | $459.00M derived: sum of 2 quarters · filed 2018-02-27 | $575.00M derived: sum of 3 quarters · filed 2018-02-27 | $442.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $213.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $329.50M derived: sum of 2 quarters · filed 2018-02-27 | $197.40M derived: sum of 3 quarters · filed 2018-02-27 | $467.30M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $116.00M 10-Q · filed 2015-11-09 | -$16.10M derived: sum of 2 quarters · filed 2016-11-08 | $253.80M 10-Q · filed 2016-11-08 | $480.10M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | -$132.10M 10-Q · filed 2016-08-08 | -$129.50M 10-Q · filed 2015-08-10 | $137.80M 10-Q · filed 2016-08-08 | $145.40M 10-Q · filed 2015-08-10 | $364.10M derived: sum of 3 quarters · filed 2017-03-01 | $619.30M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $269.90M 10-Q · filed 2016-05-10 | $274.90M 10-Q · filed 2015-05-07 | $496.20M derived: sum of 2 quarters · filed 2017-03-01 | $751.40M derived: sum of 3 quarters · filed 2017-03-01 | $1.01B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $226.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $481.50M derived: sum of 2 quarters · filed 2017-03-01 | $742.40M derived: sum of 3 quarters · filed 2017-03-01 | $1.04B 10-K · filed 2017-03-01 | $1.03B 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $255.20M 10-Q · filed 2015-11-09 | $251.20M 10-Q · filed 2014-11-05 | $516.10M derived: sum of 2 quarters · filed 2015-11-09 | $811.00M 10-Q · filed 2015-11-09 | $808.90M 10-Q · filed 2014-11-05 | $1.16B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $260.90M 10-Q · filed 2015-08-10 | $259.30M 10-Q · filed 2014-08-07 | $561.00M 10-Q · filed 2015-08-10 | $557.70M 10-Q · filed 2014-08-07 | $909.30M derived: sum of 3 quarters · filed 2016-02-29 | $1.12B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $300.10M 10-Q · filed 2015-05-07 | $298.40M 10-Q · filed 2014-05-06 | $648.40M derived: sum of 2 quarters · filed 2016-02-29 | $860.10M derived: sum of 3 quarters · filed 2016-02-29 | $1.07B derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $348.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $560.00M derived: sum of 2 quarters · filed 2016-02-29 | $770.40M derived: sum of 3 quarters · filed 2016-02-29 | $1.07B 10-K · filed 2016-02-29 | $1.04B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $211.70M 10-Q · filed 2014-11-05 | $422.10M derived: sum of 2 quarters · filed 2014-11-05 | $720.30M 10-Q · filed 2014-11-05 | $920.80M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-06-30 | $210.40M 10-Q · filed 2014-08-07 | $508.60M 10-Q · filed 2014-08-07 | $709.10M derived: sum of 3 quarters · filed 2015-02-23 | $958.50M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-03-31 | $298.20M 10-Q · filed 2014-05-06 | $498.70M derived: sum of 2 quarters · filed 2015-02-23 | $748.10M derived: sum of 3 quarters · filed 2015-02-23 | $1.05B derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2012-12-31 | $200.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $449.90M derived: sum of 2 quarters · filed 2015-02-23 | $751.80M derived: sum of 3 quarters · filed 2015-02-23 | $1.05B 10-K · filed 2015-02-23 | ||||
| 2012-09-30 | $249.40M 10-Q · filed 2013-11-12 | $551.30M derived: sum of 2 quarters · filed 2013-11-12 | $846.90M 10-Q · filed 2013-11-12 | $1.05B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $301.90M 10-Q · filed 2013-08-07 | $597.50M 10-Q · filed 2013-08-07 | $798.70M derived: sum of 3 quarters · filed 2014-02-28 | $1.07B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $295.60M 10-Q · filed 2013-05-08 | $496.80M derived: sum of 2 quarters · filed 2014-02-28 | $763.40M derived: sum of 3 quarters · filed 2014-02-28 | $1.02B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $201.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $467.80M derived: sum of 2 quarters · filed 2014-02-28 | $726.90M derived: sum of 3 quarters · filed 2014-02-28 | $1.02B 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $266.60M 10-Q · filed 2012-11-06 | $525.70M derived: sum of 2 quarters · filed 2012-11-06 | $822.90M 10-Q · filed 2012-11-06 | $945.80M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $259.10M 10-Q · filed 2012-08-07 | $556.30M 10-Q · filed 2012-08-07 | $679.20M derived: sum of 3 quarters · filed 2013-02-27 | $950.80M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $297.20M 10-Q · filed 2012-05-03 | $420.10M derived: sum of 2 quarters · filed 2013-02-27 | $691.70M derived: sum of 3 quarters · filed 2013-02-27 | $919.80M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $122.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $394.50M derived: sum of 2 quarters · filed 2013-02-27 | $622.60M derived: sum of 3 quarters · filed 2013-02-27 | $916.70M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $271.60M 10-Q · filed 2011-11-02 | $499.70M derived: sum of 2 quarters · filed 2011-11-02 | $793.80M 10-Q · filed 2011-11-02 | $1.03B derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $228.10M 10-Q · filed 2011-08-08 | $522.20M 10-Q · filed 2011-08-08 | $760.70M derived: sum of 3 quarters · filed 2012-02-27 | $964.70M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $294.10M 10-Q · filed 2011-05-05 | $532.60M derived: sum of 2 quarters · filed 2012-02-27 | $736.60M derived: sum of 3 quarters · filed 2012-02-27 | $1.03B derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $238.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $442.50M derived: sum of 2 quarters · filed 2012-02-27 | $739.00M derived: sum of 3 quarters · filed 2012-02-27 | $1.02B 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $204.00M 10-Q · filed 2010-11-03 | $500.50M derived: sum of 2 quarters · filed 2010-11-03 | $780.30M 10-Q · filed 2010-11-03 | $1.02B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-30 | $296.50M 10-Q · filed 2010-08-05 | $576.30M 10-Q · filed 2010-08-05 | $816.00M derived: sum of 3 quarters · filed 2011-02-25 | $1.03B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-31 | $279.80M 10-Q · filed 2010-05-05 | $519.50M derived: sum of 2 quarters · filed 2011-02-25 | $729.80M derived: sum of 3 quarters · filed 2011-02-25 | $1.04B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-31 | $239.70M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $450.00M derived: sum of 2 quarters · filed 2011-02-25 | $758.40M derived: sum of 3 quarters · filed 2011-02-25 | $1.09B 10-K · filed 2011-02-25 | ||||
| 2008-09-30 | $210.30M 10-Q · filed 2009-11-04 | $518.70M derived: sum of 2 quarters · filed 2009-11-04 | $850.30M 10-Q · filed 2009-11-04 | |||||
| 2008-06-30 | $308.40M 10-Q/A · filed 2009-08-17 | $640.00M 10-Q/A · filed 2009-08-17 | ||||||
| 2007-12-31 | $1.13B 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |